QUESTIONS| Event Date/Time: Feb 20, 2012 | End Date/Time: Feb 22, 2012 |
| Early Registration Date: Oct 21, 2011 |
Report as SpamDescription
Pharma IQ is delighted to present its 9th Annual PAT and Quality by Design event to be held in London, February 2012. With an extensive agenda we provide a platform for knowledge acquisition, networking and first hand experience from fellow industry specialists and regulatory bodies.
5 Great Reasons to Attend
• Hear first hand from the regulators! Gain insightful knowledge on how to interpret regulatory guidance, understand best practice approaches to writing submissions and gain feedback directly from the SWISSMEDIC and BfArM on previous submissions
• Truly understand the benefits and ROI of QbD and learn how to successfully present QbD's business case to senior management with feedback from PHILIP MORRIS INTERNATIONAL
• Apply PAT to biologic manufacturing by understanding how to successfully use its tools and techniques in a biotechnology environment: GENZYME share their experience
• Create and effective quality risk framework with expert insight from PFIZER
• Discuss experiences, thoughts and feedback with leading industry speakers from NAPP PHARMACEUTICALS, PMI and STEP CHANGE PHARMA by participating in interactive round table discussions assessing the financial benefits of PAT and QbD, risk management guidelines and PAT and QbD in the biopharmaceutical field.
Book your place today!
5 Great Reasons to Attend
• Hear first hand from the regulators! Gain insightful knowledge on how to interpret regulatory guidance, understand best practice approaches to writing submissions and gain feedback directly from the SWISSMEDIC and BfArM on previous submissions
• Truly understand the benefits and ROI of QbD and learn how to successfully present QbD's business case to senior management with feedback from PHILIP MORRIS INTERNATIONAL
• Apply PAT to biologic manufacturing by understanding how to successfully use its tools and techniques in a biotechnology environment: GENZYME share their experience
• Create and effective quality risk framework with expert insight from PFIZER
• Discuss experiences, thoughts and feedback with leading industry speakers from NAPP PHARMACEUTICALS, PMI and STEP CHANGE PHARMA by participating in interactive round table discussions assessing the financial benefits of PAT and QbD, risk management guidelines and PAT and QbD in the biopharmaceutical field.
Book your place today!
